Warning Letter Should Not Hinder Taxus Liberté Approval – Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific estimates it will be ready by June for FDA to re-inspect its facilities to confirm that the quality-control problems cited in a sweeping Jan. 25 warning letter have been fixed
You may also be interested in...
Boston Scientific Expects To Be Ready For FDA Inspections By Summer
Boston Scientific says it will be ready by the end of the second quarter to begin FDA inspections that will resolve a year-old, corporate-wide quality systems warning letter
Boston Scientific Expects To Be Ready For FDA Inspections By Summer
Boston Scientific says it will be ready by the end of the second quarter to begin FDA inspections that will resolve a year-old, corporate-wide quality systems warning letter
With 18% Revenue Drop, Guidant Unit Drags Down Boston Scientific Growth
Boston Scientific says it will be another three to five years before it realizes double-digit growth from its acquisition of Guidant